Biblio

Export 136 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is R  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
R
V. K. Ramanan, Przybelski, S. A., Graff-Radford, J., Castillo, A. M., Lowe, V. J., Mielke, M. M., Roberts, R. O., Reid, R. I., Knopman, D. S., Jack, C. R., Petersen, R. C., and Vemuri, P., “Statins and Brain Health: Alzheimer's Disease and Cerebrovascular Disease Biomarkers in Older Adults.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1345-1352, 2018.
S. Ramanan, Flanagan, E., Leyton, C. E., Villemagne, V. L., Rowe, C. C., Hodges, J. R., and Hornberger, M., “Non-Verbal Episodic Memory Deficits in Primary Progressive Aphasias are Highly Predictive of Underlying Amyloid Pathology.”, J Alzheimers Dis, vol. 51, no. 2, pp. 367-76, 2016.
V. K. Ramanan, Heckman, M. G., Przybelski, S. A., Lesnick, T. G., Lowe, V. J., Graff-Radford, J., Mielke, M., Jack, C. R., Knopman, D. S., Petersen, R. C., Ross, O. A., and Vemuri, P., “Polygenic Scores of Alzheimer's Disease Risk Genes Add Only Modestly to APOE in Explaining Variation in Amyloid PET Burden.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1615-1625, 2022.
C. Ramos, Villalba, C., García, J., Lanata, S., López, H., Aguillón, D., Cordano, C., Madrigal, L., Aguirre-Acevedo, D. C., and Lopera, F., “Substance Use-Related Cognitive Decline in Families with Autosomal Dominant Alzheimer's Disease: A Cohort Study.”, J Alzheimers Dis, vol. 85, no. 4, pp. 423-1439, 2021.
M. Ramos-Goicoa, Galdo-Álvarez, S., Díaz, F., and Zurrón, M., “Effect of Normal Aging and of Mild Cognitive Impairment on Event-Related Potentials to a Stroop Color-Word Task.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1487-501, 2016.
H. Ramzaoui, Faure, S., and Spotorno, S., “Alzheimer's Disease, Visual Search, and Instrumental Activities of Daily Living: A Review and a New Perspective on Attention and Eye Movements.”, J Alzheimers Dis, vol. 66, no. 3, pp. 901-925, 2018.
J. Subhash Rane, Bhaumik, P., and Panda, D., “Curcumin Inhibits Tau Aggregation and Disintegrates Preformed Tau Filaments in vitro.”, J Alzheimers Dis, vol. 60, no. 3, pp. 999-1014, 2017.
G. Ransmayr, Hermann, P., Sallinger, K., Benke, T., Seiler, S., Dal-Bianco, P., Marksteiner, J., Defrancesco, M., Sanin, G., Struhal, W., Guger, M., Vosko, M., Hagenauer, K., Lehner, R., Futschik, A., and Schmidt, R., “Caregiving and Caregiver Burden in Dementia Home Care: Results from the Prospective Dementia Registry (PRODEM) of the Austrian Alzheimer Society.”, J Alzheimers Dis, vol. 63, no. 1, pp. 103-114, 2018.
S. M. Rao, Galioto, R., Sokolowski, M., Pierce, M., Penn, L., Sturtevant, A., Skugor, B., Anstead, B., Leverenz, J. B., Schindler, D., Blum, D., Alberts, J. L., and Posk, L., “Cleveland Clinic Cognitive Battery (C3B): Normative, Reliability, and Validation Studies of a Self-Administered Computerized Tool for Screening Cognitive Dysfunction in Primary Care.”, J Alzheimers Dis, vol. 92, no. 3, pp. 1051-1066, 2023.
H. V. Rao, Bihaqi, S. W., Iannucci, J., Sen, A., and Grammas, P., “Thrombin Signaling Contributes to High Glucose-Induced Injury of Human Brain Microvascular Endothelial Cells.”, J Alzheimers Dis, vol. 79, no. 1, pp. 211-224, 2021.
C. Rattanabannakit, Risacher, S. L., Gao, S., Lane, K. A., Brown, S. A., McDonald, B. C., Unverzagt, F. W., Apostolova, L. G., Saykin, A. J., and Farlow, M. R., “The Cognitive Change Index as a Measure of Self and Informant Perception of Cognitive Decline: Relation to Neuropsychological Tests.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1145-55, 2016.
B. - S. Rauchmann, Sadlon, A., and Perneczky, R., “Soluble TREM2 and Inflammatory Proteins in Alzheimer's Disease Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1615-1626, 2020.
A. Raunio, Myllykangas, L., Kero, M., Polvikoski, T., Paetau, A., and Oinas, M., “Amygdala α-Synuclein Pathology in the Population-Based Vantaa 85+ Study.”, J Alzheimers Dis, vol. 58, no. 3, pp. 669-674, 2017.
R. Ravona-Springer, Schnaider-Beeri, M., and Goldbourt, U., “Triceps and Subscapular Skinfold in Men Aged 40-65 and Dementia Prevalence 36 Years Later.”, J Alzheimers Dis, vol. 57, no. 3, pp. 873-883, 2017.
I. Rawtaer, Gao, Q., Nyunt, M. Shwe Zin, Feng, L., Chong, M. Sian, Lim, W. Shiong, Lee, T. - S., Yap, P., Yap, K. Bee, and Ng, T. Pin, “Psychosocial Risk and Protective Factors and Incident Mild Cognitive Impairment and Dementia in Community Dwelling Elderly: Findings from the Singapore Longitudinal Ageing Study.”, J Alzheimers Dis, vol. 57, no. 2, pp. 603-611, 2017.
M. Reale, D'Angelo, C., Costantini, E., Di Nicola, M., Yarla, N. Sastry, Kamal, M. Amjad, Salvador, N., and Perry, G., “Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 62, no. 1, pp. 467-476, 2018.
G. W. Rebok, Ball, K., Guey, L. T., Jones, R. N., Kim, H. - Y., King, J. W., Marsiske, M., Morris, J. N., Tennstedt, S. L., Unverzagt, F. W., and Willis, S. L., “Ten-year effects of the advanced cognitive training for independent and vital elderly cognitive training trial on cognition and everyday functioning in older adults.”, J Am Geriatr Soc, vol. 62, no. 1, pp. 16-24, 2014.
V. Redaelli, Salsano, E., Colleoni, L., Corbetta, P., Tringali, G., Del Sole, A., Giaccone, G., and Rossi, G., “Frontotemporal Dementia and Chorea Associated with a Compound Heterozygous TREM2 Mutation.”, J Alzheimers Dis, vol. 63, no. 1, pp. 195-201, 2018.
H. P Reddy, “A Critical Assessment of Research on Neurotransmitters in Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 4, pp. 969-974, 2017.
H. P Reddy, Manczak, M., Yin, X. L., Grady, M. Catherine, Mitchell, A., Tonk, S., Kuruva, C. Sekhar, Bhatti, J. Singh, Kandimalla, R., Vijayan, M., Kumar, S., Wang, R., Pradeepkiran, J. Adi, Ogunmokun, G., Thamarai, K., Quesada, K., Boles, A., and Reddy, A. P., “Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 3, pp. 843-866, 2018.
H. P Reddy, Manczak, M., and Yin, X. L., “Mitochondria-Division Inhibitor 1 Protects Against Amyloid-β induced Mitochondrial Fragmentation and Synaptic Damage in Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 1, pp. 147-162, 2017.
H. P Reddy, Manczak, M., Yin, X. L., and Reddy, A. P., “Synergistic Protective Effects of Mitochondrial Division Inhibitor 1 and Mitochondria-Targeted Small Peptide SS31 in Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1549-1565, 2018.
M. R. Redston, Hilmer, S. N., McLachlan, A. J., Clough, A. J., and Gnjidic, D., “Prevalence of Potentially Inappropriate Medication Use in Older Inpatients with and without Cognitive Impairment: A Systematic Review.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1639-1652, 2018.
C. Reed, Happich, M., Argimon, J. Maria, Haro, J. Maria, Wimo, A., Bruno, G., Dodel, R., Jones, R. W., Vellas, B., and Belger, M., “What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study.”, J Alzheimers Dis, vol. 57, no. 3, pp. 797-812, 2017.
Â. Rego, Viana, S. D., Ribeiro, C. A. Fontes, Rodrigues-Santos, P., and Pereira, F. C., “Monophosphoryl Lipid-A: A Promising Tool for Alzheimer's Disease Toll.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1189-202, 2016.

Pages